Skip to content

Clinical Study of High Intensity Focused Ultrasound (HIFU) on Coagulation System in the Treatment of Uterine Leiomyomas

Clinical Study of High Intensity Focused Ultrasound (HIFU) on Coagulation System in the Treatment of Uterine Leiomyomas

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036928
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine leiomyoma

Interventions

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Patients with clinical and imaging diagnosis of uterine fibroids. 2.The patients have great desire for HIFU therapy and strongly request to preserve the uterus. 3.The patients have complete information of coagulation and MRI examination before and the next of HIFU treatment.

Exclusion criteria

Exclusion criteria: 1. The patients have a history of thrombotic disease or coagulation disorder. 2. BMI>30 kg/?. 3. The patients have alcohol or tobacco habit. 4. The patients with abnormal liver or renal function. 5. pregnancy,lactation or menstruation; 6. acute pelvic inflammation. 7. suspected gynecological malignancy; 8. history of radiotherapy; 9. inability to communicate with doctors during the procedure.

Design outcomes

Primary

MeasureTime frame
P-selectin;D-dimer;platelet;Endothelin - 1;TAFI;Thrombomodulin;

Countries

China

Contacts

Public ContactXiaofei Zhang

Shanghai First Maternity and Infant Hospital

sophia_will@163.com+86 15618726390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026